Imatinib Mesylate (CAS 220127-57-1): A Key Pharmaceutical Intermediate
In the dynamic landscape of pharmaceutical development and manufacturing, the availability of high-quality intermediates is foundational. Imatinib Mesylate (CAS 220127-57-1) has emerged as a significant pharmaceutical intermediate, indispensable for the synthesis of various Active Pharmaceutical Ingredients (APIs), especially within the realm of targeted therapies and oncology. Understanding its properties and the importance of reliable sourcing is key for industry professionals.
Imatinib Mesylate is chemically defined by its molecular formula, C29H31N7O.CH4O3S, and a molecular weight of 589.71. It typically presents as an off-white solid, and its utility in pharmaceutical synthesis is heavily reliant on its purity. Manufacturers strive to achieve and maintain a purity level of ≥99%, ensuring that the compound is free from contaminants that could compromise the integrity of the final API. For procurement managers and R&D scientists, sourcing this intermediate from a trusted manufacturer like us, who adheres to strict quality control measures, is a critical step in ensuring product quality and regulatory compliance.
The primary application of Imatinib Mesylate lies in its role as a precursor or key building block in the synthesis of APIs. Its specific molecular structure makes it suitable for incorporation into complex therapeutic molecules. While its direct therapeutic use is separate, its significance as an intermediate allows for the cost-effective and efficient production of vital medications. Researchers also utilize it in laboratory settings to study biochemical pathways and enzyme inhibition, contributing to the broader advancement of pharmaceutical science.
For companies looking to purchase Imatinib Mesylate, engaging with a direct manufacturer offers numerous advantages. As a supplier based in China, we can provide competitive pricing, especially for bulk orders, and ensure a stable supply chain. Our manufacturing process is designed to consistently yield high-purity Imatinib Mesylate, meeting the demanding specifications of the pharmaceutical industry. We offer flexible terms of sale and robust logistical support to facilitate global distribution, ensuring that our clients can reliably integrate our product into their production cycles.
In conclusion, Imatinib Mesylate is more than just a chemical compound; it's a critical enabler in the pharmaceutical industry. Its high purity and specific applications make it a sought-after intermediate. For any organization looking to buy Imatinib Mesylate, partnering with a reputable manufacturer that prioritizes quality, consistency, and reliable supply is the most strategic approach to ensure project success and product integrity.
Perspectives & Insights
Data Seeker X
“For any organization looking to buy Imatinib Mesylate, partnering with a reputable manufacturer that prioritizes quality, consistency, and reliable supply is the most strategic approach to ensure project success and product integrity.”
Chem Reader AI
“In the dynamic landscape of pharmaceutical development and manufacturing, the availability of high-quality intermediates is foundational.”
Agile Vision 2025
“Imatinib Mesylate (CAS 220127-57-1) has emerged as a significant pharmaceutical intermediate, indispensable for the synthesis of various Active Pharmaceutical Ingredients (APIs), especially within the realm of targeted therapies and oncology.”